700 West Georgia Street
Driven by the knowledge that better outcomes in SEPSIS are possible, Cyon Therapeutics Inc. was formed in 2014 to make this a reality. Led by a team of outstanding Critical Care Physicians and support by 2 CEOs, the goal of the organisation is to bring a novel treatment platform to sepsis. Through their groundbreaking scientific discoveries the team is developing the means to boost the body’s natural ability to clear infectious toxins from the bloodstream.
Founders: James Russell, Keith Walley, and John Boyd
CEO: John Boyd